Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers
It is well known that disorders of coagulation and fibrinolysis play a major role in the development of organ dysfunction during sepsis. Furthermore, the importance of the early initiation of anticoagulation therapy for severe cases has been emphasized based on the success of recent clinical trials....
Gespeichert in:
Veröffentlicht in: | Shock (Augusta, Ga.) Ga.), 2005, Vol.23 (1), p.25-29 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 29 |
---|---|
container_issue | 1 |
container_start_page | 25 |
container_title | Shock (Augusta, Ga.) |
container_volume | 23 |
creator | IBA, Toshiaki KIDOKORO, Akio FUKUNAGA, Masaki SUGIYAMA, Kazuyoshi SAWADA, Tomohiro KATO, Hisaaki |
description | It is well known that disorders of coagulation and fibrinolysis play a major role in the development of organ dysfunction during sepsis. Furthermore, the importance of the early initiation of anticoagulation therapy for severe cases has been emphasized based on the success of recent clinical trials. The purpose of this study is to search for useful markers for predicting organ dysfunction. Plasma samples were prospectively collected from 78 patients within 48 h after the onset of sepsis. Hemostatic markers and endothelial damage markers were compared between the patients with and without organ dysfunction. The WBC and platelet counts were not different between the groups. In contrast, fibrin/fibrinogen degradation products, D-dimer, thrombin-antithrombin complex, plasmin alpha2-antiplasmin complex, soluble fibrin, and total plasminogen activator inhibitor-1 were significantly higher, and the antithrombin activity and protein C levels were lower in the patients with organ dysfunction. Thus, the changes in the hemostatic molecular markers were associated with organ dysfunction from an early stage of sepsis, and antithrombin and protein C activities were found to be the most reliable markers. |
doi_str_mv | 10.1097/01.shk.0000144422.32647.b6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67327991</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67327991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-927196c099d3f0d90db900df0cf259d89dc37c35a0ffafeccf160e4c23014cd3</originalsourceid><addsrcrecordid>eNpFkctuHCEQRVEUK3ac_EKEIiW7bhePhpCdZeUlWcrGe0RD4SHubibQY8tbf7mJZ6JhQ4k6tyjdS8hHBj0Doy-A9XVz10M7TErJeS-4krof1StyxgYJHQxMvm41aNFxwfkpeVvrHwAuhdFvyCkbFJOM6zPydFlr9smtKS90xPUBcaHrBmnFeyxpfaQ5tnpbU6VuCS8tv3HLLVaaFrrBOde1qT2d84R-N7lCZ1fusOz5e1f3j7iE3MRTchMNbna3-J97R06imyq-P9zn5Ob7t5urn9317x-_ri6vOy_VsHaGa2aUB2OCiBAMhNEAhAg-8sGELyZ4ob0YHMToInofmQKUnovmkg_inHzej92W_HeHdbVzqh6nyS2Yd9UqLbg2hjXw6x70JddaMNptSW3XR8vA_gvAArMtAHsMwL4EYEfVxB8Ov-zGGcNRenC8AZ8OQHPGTbG4xad65JQwhhshngH7TJM1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67327991</pqid></control><display><type>article</type><title>Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>IBA, Toshiaki ; KIDOKORO, Akio ; FUKUNAGA, Masaki ; SUGIYAMA, Kazuyoshi ; SAWADA, Tomohiro ; KATO, Hisaaki</creator><creatorcontrib>IBA, Toshiaki ; KIDOKORO, Akio ; FUKUNAGA, Masaki ; SUGIYAMA, Kazuyoshi ; SAWADA, Tomohiro ; KATO, Hisaaki</creatorcontrib><description>It is well known that disorders of coagulation and fibrinolysis play a major role in the development of organ dysfunction during sepsis. Furthermore, the importance of the early initiation of anticoagulation therapy for severe cases has been emphasized based on the success of recent clinical trials. The purpose of this study is to search for useful markers for predicting organ dysfunction. Plasma samples were prospectively collected from 78 patients within 48 h after the onset of sepsis. Hemostatic markers and endothelial damage markers were compared between the patients with and without organ dysfunction. The WBC and platelet counts were not different between the groups. In contrast, fibrin/fibrinogen degradation products, D-dimer, thrombin-antithrombin complex, plasmin alpha2-antiplasmin complex, soluble fibrin, and total plasminogen activator inhibitor-1 were significantly higher, and the antithrombin activity and protein C levels were lower in the patients with organ dysfunction. Thus, the changes in the hemostatic molecular markers were associated with organ dysfunction from an early stage of sepsis, and antithrombin and protein C activities were found to be the most reliable markers.</description><identifier>ISSN: 1073-2322</identifier><identifier>EISSN: 1540-0514</identifier><identifier>DOI: 10.1097/01.shk.0000144422.32647.b6</identifier><identifier>PMID: 15614127</identifier><language>eng</language><publisher>Augusta, GA: BioMedical Press</publisher><subject>Adult ; Aged ; alpha-2-Antiplasmin - biosynthesis ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Antithrombin III ; Antithrombins - biosynthesis ; Area Under Curve ; Biological and medical sciences ; Biomarkers - blood ; Blood Cell Count ; Blood Coagulation Tests ; Blood. Blood coagulation. Reticuloendothelial system ; Emergency and intensive care: infection, septic shock ; Endothelium, Vascular - cytology ; Female ; Fibrin - biosynthesis ; Fibrin Fibrinogen Degradation Products - biosynthesis ; Hemostasis ; Humans ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Peptide Hydrolases - blood ; Pharmacology. Drug treatments ; Plasminogen Activator Inhibitor 1 - blood ; ROC Curve ; Sepsis - blood ; Sepsis - immunology ; Sepsis - pathology ; Time Factors</subject><ispartof>Shock (Augusta, Ga.), 2005, Vol.23 (1), p.25-29</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-927196c099d3f0d90db900df0cf259d89dc37c35a0ffafeccf160e4c23014cd3</citedby><cites>FETCH-LOGICAL-c465t-927196c099d3f0d90db900df0cf259d89dc37c35a0ffafeccf160e4c23014cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16399293$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15614127$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>IBA, Toshiaki</creatorcontrib><creatorcontrib>KIDOKORO, Akio</creatorcontrib><creatorcontrib>FUKUNAGA, Masaki</creatorcontrib><creatorcontrib>SUGIYAMA, Kazuyoshi</creatorcontrib><creatorcontrib>SAWADA, Tomohiro</creatorcontrib><creatorcontrib>KATO, Hisaaki</creatorcontrib><title>Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers</title><title>Shock (Augusta, Ga.)</title><addtitle>Shock</addtitle><description>It is well known that disorders of coagulation and fibrinolysis play a major role in the development of organ dysfunction during sepsis. Furthermore, the importance of the early initiation of anticoagulation therapy for severe cases has been emphasized based on the success of recent clinical trials. The purpose of this study is to search for useful markers for predicting organ dysfunction. Plasma samples were prospectively collected from 78 patients within 48 h after the onset of sepsis. Hemostatic markers and endothelial damage markers were compared between the patients with and without organ dysfunction. The WBC and platelet counts were not different between the groups. In contrast, fibrin/fibrinogen degradation products, D-dimer, thrombin-antithrombin complex, plasmin alpha2-antiplasmin complex, soluble fibrin, and total plasminogen activator inhibitor-1 were significantly higher, and the antithrombin activity and protein C levels were lower in the patients with organ dysfunction. Thus, the changes in the hemostatic molecular markers were associated with organ dysfunction from an early stage of sepsis, and antithrombin and protein C activities were found to be the most reliable markers.</description><subject>Adult</subject><subject>Aged</subject><subject>alpha-2-Antiplasmin - biosynthesis</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Antithrombin III</subject><subject>Antithrombins - biosynthesis</subject><subject>Area Under Curve</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Blood Cell Count</subject><subject>Blood Coagulation Tests</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Emergency and intensive care: infection, septic shock</subject><subject>Endothelium, Vascular - cytology</subject><subject>Female</subject><subject>Fibrin - biosynthesis</subject><subject>Fibrin Fibrinogen Degradation Products - biosynthesis</subject><subject>Hemostasis</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Peptide Hydrolases - blood</subject><subject>Pharmacology. Drug treatments</subject><subject>Plasminogen Activator Inhibitor 1 - blood</subject><subject>ROC Curve</subject><subject>Sepsis - blood</subject><subject>Sepsis - immunology</subject><subject>Sepsis - pathology</subject><subject>Time Factors</subject><issn>1073-2322</issn><issn>1540-0514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkctuHCEQRVEUK3ac_EKEIiW7bhePhpCdZeUlWcrGe0RD4SHubibQY8tbf7mJZ6JhQ4k6tyjdS8hHBj0Doy-A9XVz10M7TErJeS-4krof1StyxgYJHQxMvm41aNFxwfkpeVvrHwAuhdFvyCkbFJOM6zPydFlr9smtKS90xPUBcaHrBmnFeyxpfaQ5tnpbU6VuCS8tv3HLLVaaFrrBOde1qT2d84R-N7lCZ1fusOz5e1f3j7iE3MRTchMNbna3-J97R06imyq-P9zn5Ob7t5urn9317x-_ri6vOy_VsHaGa2aUB2OCiBAMhNEAhAg-8sGELyZ4ob0YHMToInofmQKUnovmkg_inHzej92W_HeHdbVzqh6nyS2Yd9UqLbg2hjXw6x70JddaMNptSW3XR8vA_gvAArMtAHsMwL4EYEfVxB8Ov-zGGcNRenC8AZ8OQHPGTbG4xad65JQwhhshngH7TJM1</recordid><startdate>2005</startdate><enddate>2005</enddate><creator>IBA, Toshiaki</creator><creator>KIDOKORO, Akio</creator><creator>FUKUNAGA, Masaki</creator><creator>SUGIYAMA, Kazuyoshi</creator><creator>SAWADA, Tomohiro</creator><creator>KATO, Hisaaki</creator><general>BioMedical Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2005</creationdate><title>Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers</title><author>IBA, Toshiaki ; KIDOKORO, Akio ; FUKUNAGA, Masaki ; SUGIYAMA, Kazuyoshi ; SAWADA, Tomohiro ; KATO, Hisaaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-927196c099d3f0d90db900df0cf259d89dc37c35a0ffafeccf160e4c23014cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>alpha-2-Antiplasmin - biosynthesis</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Antithrombin III</topic><topic>Antithrombins - biosynthesis</topic><topic>Area Under Curve</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Blood Cell Count</topic><topic>Blood Coagulation Tests</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Emergency and intensive care: infection, septic shock</topic><topic>Endothelium, Vascular - cytology</topic><topic>Female</topic><topic>Fibrin - biosynthesis</topic><topic>Fibrin Fibrinogen Degradation Products - biosynthesis</topic><topic>Hemostasis</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Peptide Hydrolases - blood</topic><topic>Pharmacology. Drug treatments</topic><topic>Plasminogen Activator Inhibitor 1 - blood</topic><topic>ROC Curve</topic><topic>Sepsis - blood</topic><topic>Sepsis - immunology</topic><topic>Sepsis - pathology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>IBA, Toshiaki</creatorcontrib><creatorcontrib>KIDOKORO, Akio</creatorcontrib><creatorcontrib>FUKUNAGA, Masaki</creatorcontrib><creatorcontrib>SUGIYAMA, Kazuyoshi</creatorcontrib><creatorcontrib>SAWADA, Tomohiro</creatorcontrib><creatorcontrib>KATO, Hisaaki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Shock (Augusta, Ga.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>IBA, Toshiaki</au><au>KIDOKORO, Akio</au><au>FUKUNAGA, Masaki</au><au>SUGIYAMA, Kazuyoshi</au><au>SAWADA, Tomohiro</au><au>KATO, Hisaaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers</atitle><jtitle>Shock (Augusta, Ga.)</jtitle><addtitle>Shock</addtitle><date>2005</date><risdate>2005</risdate><volume>23</volume><issue>1</issue><spage>25</spage><epage>29</epage><pages>25-29</pages><issn>1073-2322</issn><eissn>1540-0514</eissn><abstract>It is well known that disorders of coagulation and fibrinolysis play a major role in the development of organ dysfunction during sepsis. Furthermore, the importance of the early initiation of anticoagulation therapy for severe cases has been emphasized based on the success of recent clinical trials. The purpose of this study is to search for useful markers for predicting organ dysfunction. Plasma samples were prospectively collected from 78 patients within 48 h after the onset of sepsis. Hemostatic markers and endothelial damage markers were compared between the patients with and without organ dysfunction. The WBC and platelet counts were not different between the groups. In contrast, fibrin/fibrinogen degradation products, D-dimer, thrombin-antithrombin complex, plasmin alpha2-antiplasmin complex, soluble fibrin, and total plasminogen activator inhibitor-1 were significantly higher, and the antithrombin activity and protein C levels were lower in the patients with organ dysfunction. Thus, the changes in the hemostatic molecular markers were associated with organ dysfunction from an early stage of sepsis, and antithrombin and protein C activities were found to be the most reliable markers.</abstract><cop>Augusta, GA</cop><pub>BioMedical Press</pub><pmid>15614127</pmid><doi>10.1097/01.shk.0000144422.32647.b6</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1073-2322 |
ispartof | Shock (Augusta, Ga.), 2005, Vol.23 (1), p.25-29 |
issn | 1073-2322 1540-0514 |
language | eng |
recordid | cdi_proquest_miscellaneous_67327991 |
source | MEDLINE; Journals@Ovid LWW Legacy Archive; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
subjects | Adult Aged alpha-2-Antiplasmin - biosynthesis Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antithrombin III Antithrombins - biosynthesis Area Under Curve Biological and medical sciences Biomarkers - blood Blood Cell Count Blood Coagulation Tests Blood. Blood coagulation. Reticuloendothelial system Emergency and intensive care: infection, septic shock Endothelium, Vascular - cytology Female Fibrin - biosynthesis Fibrin Fibrinogen Degradation Products - biosynthesis Hemostasis Humans Intensive care medicine Male Medical sciences Middle Aged Peptide Hydrolases - blood Pharmacology. Drug treatments Plasminogen Activator Inhibitor 1 - blood ROC Curve Sepsis - blood Sepsis - immunology Sepsis - pathology Time Factors |
title | Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T15%3A56%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20between%20the%20severity%20of%20sepsis%20and%20the%20changes%20in%20hemostatic%20molecular%20markers%20and%20vascular%20endothelial%20damage%20markers&rft.jtitle=Shock%20(Augusta,%20Ga.)&rft.au=IBA,%20Toshiaki&rft.date=2005&rft.volume=23&rft.issue=1&rft.spage=25&rft.epage=29&rft.pages=25-29&rft.issn=1073-2322&rft.eissn=1540-0514&rft_id=info:doi/10.1097/01.shk.0000144422.32647.b6&rft_dat=%3Cproquest_cross%3E67327991%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67327991&rft_id=info:pmid/15614127&rfr_iscdi=true |